Background: There are no reports of concurrent chemoradiotherapy for gastric cancer with peritoneal oligometastases.
Case Description: A 70-year-old man with gastric cancer and peritoneal oligometastases received concurrent adaptive radiotherapy and oral S-1. After radiotherapy, S-1 was discontinued, and 2 years later the tumor had completely regressed, with no recurrence or metastasis 6 years after radiotherapy.
Conclusion: Peritoneal oligometastatic gastric cancer may be a candidate for curative treatment with concurrent adaptive radiotherapy and oral S-1.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.48095/ccko2024286 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!